Search research articles
Contact Us
Filters
Showing results (131-140 of 157) with videos related to
Page
of 16
Sort By:
Circulation
|
January 11, 2000
Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion
P R Sage, I S de la Lande, I Stafford, et al.
Journal of the American College of Cardiology
|
June 13, 2001
Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets
Y Y Chirkov, A S Holmes, S R Willoughby, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1984
Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics
J D Horowitz, M K Dynon, B Jarrott, et al.
The American Journal of Cardiology
|
September 15, 1992
Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects
Y Y Chirkov, J I Naujalis, S Barber, et al.
Lancet (London, England)
|
January 12, 1980
Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations
J D Horowitz, W J Lang, L G Howes, et al.
European Heart Journal
|
January 1, 1988
Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris
J D Horowitz, C A Henry, M L Syrjanen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1987
Potential functions of plasma prorenin; regional activation and tissue extraction
R L Thatcher, J S Butty, J A Whitworth, et al.
Circulation
|
April 1, 1988
Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris
J D Horowitz, C A Henry, M L Syrjanen, et al.
Circulation
|
June 1, 1983
Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease
M J Kern, P Ganz, J D Horowitz, et al.
Journal of Cardiac Failure
|
May 9, 1998
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators
B M Massie, J G Cleland, P W Armstrong, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 157) with videos related to
Sort By:
Page
of 16
Circulation
|
January 11, 2000
Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion
P R Sage, I S de la Lande, I Stafford, et al.
Journal of the American College of Cardiology
|
June 13, 2001
Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets
Y Y Chirkov, A S Holmes, S R Willoughby, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1984
Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics
J D Horowitz, M K Dynon, B Jarrott, et al.
The American Journal of Cardiology
|
September 15, 1992
Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects
Y Y Chirkov, J I Naujalis, S Barber, et al.
Lancet (London, England)
|
January 12, 1980
Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations
J D Horowitz, W J Lang, L G Howes, et al.
European Heart Journal
|
January 1, 1988
Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris
J D Horowitz, C A Henry, M L Syrjanen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1987
Potential functions of plasma prorenin; regional activation and tissue extraction
R L Thatcher, J S Butty, J A Whitworth, et al.
Circulation
|
April 1, 1988
Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris
J D Horowitz, C A Henry, M L Syrjanen, et al.
Circulation
|
June 1, 1983
Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease
M J Kern, P Ganz, J D Horowitz, et al.
Journal of Cardiac Failure
|
May 9, 1998
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators
B M Massie, J G Cleland, P W Armstrong, et al.
Page
of 16